This product is not yet available for purchase. Stock is arriving soon.
RELEASE-2 (GHRP-2)
$89.95
Ships from Australia | Discreet packaging
RELEASE-2 (GHRP-2) – The Powerful Growth Hormone Releasing Peptide for Enhanced GH & IGF-1 Levels
RELEASE-2 (GHRP-2) is a potent Growth Hormone Releasing Peptide (GHRP) designed to stimulate natural GH production and optimize IGF-1 levels. As part of the GHRP family—including GHRP-6, hexarelin, and ipamorelin—RELEASE-2 (GHRP-2) mimics ghrelin, the body’s hunger hormone, to activate the growth hormone secretagogue receptor (GHS-R1a) and trigger powerful GH release. By elevating growth hormone levels, RELEASE-2 (GHRP-2) supports fat loss, muscle recovery, and anti-aging effects, making it a valuable alternative to exogenous HGH therapy.
How RELEASE (GHRP-2) Works
Ghrelin is naturally produced by the stomach in response to fasting, sending signals to the pituitary gland to increase GH secretion. RELEASE-2 (GHRP-2) mimics this process, stimulating GH release without the need for prolonged fasting.
Research indicates that RELEASE-2 (GHRP-2) significantly elevates GH and IGF-1 levels, leading to increased fat metabolism, improved recovery, and enhanced muscle preservation. With proper dosing, GH levels can reach peak physiological levels, amplifying the benefits of natural hormone optimization.
Key Benefits of RELEASE-2 (GHRP-2)
Increased Growth Hormone & IGF-1 Levels – Enhances anabolic activity, promoting muscle growth and fat loss.Fat Loss & Lean Muscle Retention – Supports body recomposition by improving metabolism and preserving lean muscle tissue.Accelerated Recovery & Healing – Boosts cell regeneration, aiding in injury recovery, tendon repair, and anti-aging benefits.HGH Alternative – Offers a natural and cost-effective alternative to exogenous HGH therapy.Versatile Administration – Can be administered via subcutaneous, intramuscular, or intravenous injection based on preference.Optimized for Research Use – Used in studies for growth enhancement, tissue repair, and performance optimization.
Why Choose RELEASE-2 (GHRP-2)?
RELEASE-2 (GHRP-2) is an ideal solution for those seeking GH elevation without relying on synthetic HGH. Its ability to naturally enhance GH and IGF-1 levels makes it valuable for fat loss, recovery, and overall performance enhancement. With minimal side effects and flexible dosing, RELEASE-2 (GHRP-2) is a leading choice among research peptides.
Dosage Instructions
- Concentration: 5mg per vial
- Storage: Keep refrigerated (acceptable to ship unrefrigerated)
- Reconstitution: Dilute with 2.5mL of sterile or bacteriostatic water to achieve a concentration of 2000 mcg/mL
Administration Guidelines:
- Standard Dose: 50–300 mcg per injection
- Injection Frequency: 2-3 times per day for optimal GH release
- Timing: At least 30-60 minutes before meals, ensuring blood sugar levels are low for maximum effectiveness
- Cycle Duration: Typically 8-12 weeks for research purposes
Injection Methods:
- Subcutaneous (SC) – Under the skin for slow absorption
- Intramuscular (IM) – Into the muscle for faster uptake
- Intravenous (IV) – Direct bloodstream administration for immediate effect
Note: Once reconstituted, each vial should be used within 30 days for maximum potency.
Storage Instructions
- Before reconstitution: Store below -20°C (freezer storage recommended)
- After reconstitution: Store at -8°C (refrigeration acceptable)
Ingredients / Purity Report
- Active Ingredient: RELEASE-2 (GHRP-2) – L-histidyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-Lysinamide
- Other Ingredients: Sterile bacteriostatic water (for reconstitution)
Medical References
- Hu, R., Wang, Z., Peng, Q., Zou, H., Wang, H., Yu, X., Jing, X., Wang, Y., Cao, B., Bao, S., Zhang, W., Zhao, S., Ji, H., Kong, X., & Niu, Q. (2016). Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation. PLoS ONE, 11(2), 1–19.
- Lee, H.G., Choi, Y.J., Lee, S.R., Kuwayama, H., Hidari, H., & You, S.K. (2005). Effects of dietary protein and growth hormone-releasing peptide (GHRP-2) on plasma IGF-1 and IGFBPs in Holstein steers. Domestic Animal Endocrinology, 28(2), 134–146.
Disclaimer
No statements on this page have been evaluated by the the Therapeutic Goods Administration (TGA). This product is not intended to diagnose, treat, cure, or prevent any disease or illness. RELEASE-2 (GHRP-2) is strictly for research purposes only. Please refer to the TERMS OF USE for more information.





